Skip to main content
. 2019 Jan 4;51(4):1259–1268. doi: 10.4143/crt.2018.652

Fig. 3.

Fig. 3.

Comparison of overall survival of patients in the locoregional radiotherapy (LRRT) and non-LRRT group: low-risk patients (A), intermediate-risk patients (B), and high-risk patients (C). Comparison of overall survival in patients in the metastasis radiotherapy (MRT) and non-MRT group: low-risk patients (D), intermediate-risk patients (E), and high-risk patients (F).